Literature DB >> 12485469

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours.

J Plisiecka-Hałasa1, A Dansonka-Mieszkowska, A Rembiszewska, M Bidziński, J Steffen, J Kupryjańczyk.   

Abstract

We looked for NBS1 gene (602667) alterations and changes in nibrin expression in 162 human gynaecological tumours, mostly ovarian. Exons 6-8 and 10 of the NBS1 gene were evaluated by the SSCP and direct sequencing method. Nibrin expression was detected immunohistochemically with the use of the p95NBS1 (Ab-1) antibody. The 657del5 mutation (Slavic mutation) was found in two of 117 carcinomas studied (1.7%) - in both cases it was present in the germline; one of these tumours showed loss of heterozygosity (LOH) for the 657del5 mutation and loss of nibrin expression. We have found three types of novel germline intron variants: (1) two concomitant transitions (G to A) at bases 14009 and 14256; (2) C to T transition at base 13998; (3) G to C transversion at base 20035. Among the carcinomas studied, the intron variants were associated with a clear cell histological type (p = 0.004). Our results may suggest that NBS1 gene alterations contribute to the development of rare ovarian carcinomas. LOH for 657del5 in tumour tissue may support the hypothesis that the NBS1 gene functions as a tumour suppressor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12485469     DOI: 10.1017/S0003480002001227

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

1.  Bilateral Ovarian Germ Cell Tumor in a 46,XX Female with Nijmegen Breakage Syndrome and Hypergonadotropic Hypogonadism

Authors:  Malgorzata A. Krawczyk; Malgorzata Styczewska; Dorota Birkholz-Walerzak; Mariola Iliszko; Beata S. Lipska-Zietkiewicz; Wojciech Kosiak; Ninela Irga-Jaworska; Ewa Izycka-Swieszewska; Ewa Bien
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-09-21

2.  The frequency of NBN molecular variants in pediatric astrocytic tumors.

Authors:  Dorota Piekutowska-Abramczuk; Elzbieta Ciara; Ewa Popowska; Wiesława Grajkowska; Bozenna Dembowska-Bagińska; Ewa Kowalewska; Aneta Czajńska; Marta Perek-Polnik; Marcin Roszkowski; Małgorzata Syczewska; Małgorzata Krajewska-Walasek; Danuta Perek; Krystyna H Chrzanowska
Journal:  J Neurooncol       Date:  2009-07-22       Impact factor: 4.130

3.  RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.

Authors:  Katri Heikkinen; Katrin Rapakko; Sanna-Maria Karppinen; Hannele Erkko; Sakari Knuutila; Tuija Lundán; Arto Mannermaa; Anne-Lise Børresen-Dale; Ake Borg; Rosa B Barkardottir; John Petrini; Robert Winqvist
Journal:  Carcinogenesis       Date:  2006-02-12       Impact factor: 4.944

4.  Analysis of the expression of human tumor antigens in ovarian cancer tissues.

Authors:  Rouba Ali-Fehmi; Madhumita Chatterjee; Alexei Ionan; Nancy K Levin; Haitham Arabi; Sudeshna Bandyopadhyay; Jay P Shah; Christopher S Bryant; Stephen M Hewitt; Michael G O'Rand; Oleg M Alekseev; Robert Morris; Adnan Munkarah; Judith Abrams; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  NBS1 rs2735383 polymorphism is associated with an increased risk of laryngeal carcinoma.

Authors:  Xinmei Hu; Juan Liao; Huiliu Zhao; Feng Chen; Xuefeng Zhu; Jiangheng Li; Qingqing Nong
Journal:  BMC Cancer       Date:  2018-02-12       Impact factor: 4.430

Review 6.  Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2.

Authors:  David Samuel; Alexandra Diaz-Barbe; Andre Pinto; Matthew Schlumbrecht; Sophia George
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

7.  High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.

Authors:  Evgeny N Suspitsin; Nathalia Yu Sherina; Daria N Ponomariova; Anna P Sokolenko; Aglaya G Iyevleva; Tatyana V Gorodnova; Olga A Zaitseva; Olga S Yatsuk; Alexandr V Togo; Nathalia N Tkachenko; Grigory A Shiyanov; Oksana S Lobeiko; Nadezhda Yu Krylova; Dmitry E Matsko; Sergey Ya Maximov; Adel F Urmancheyeva; Nathalia V Porhanova; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2009-02-25       Impact factor: 2.857

8.  Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis.

Authors:  Meixia Lu; Jiachun Lu; Xiaobo Yang; Miao Yang; Hao Tan; Bai Yun; Luyuan Shi
Journal:  BMC Cancer       Date:  2009-04-24       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.